Zobrazeno 1 - 3
of 3
pro vyhledávání: '"George, Suzanne"'
Autor:
Schaefer IM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ischaefer@bwh.harvard.edu., Hemming ML; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Lundberg MZ; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Serrata MP; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Goldaracena I; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Liu N; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Yin P; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Paulo JA; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Gygi SP; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., George S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Morgan JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Bertagnolli MM; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Sicinska ET; Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Chu C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Zheng S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Mariño-Enríquez A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Hornick JL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Raut CP; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ou WB; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China., Demetri GD; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA., Saka SK; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany., Fletcher JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.
Publikováno v:
British journal of cancer [Br J Cancer] 2022 Nov; Vol. 127 (11), pp. 2072-2085. Date of Electronic Publication: 2022 Sep 29.
Autor:
Gelderblom H; Leiden University Medical Center, Leiden, The Netherlands. a.j.gelderblom@lumc.nl., Jones RL; The Royal Marsden Hospital and Institute of Cancer Research, London, UK., George S; Dana-Farber Cancer Institute Boston, Boston, MA, USA., Valverde Morales C; Vall D'Hebron University Hospital, Barcelona, Spain., Benson C; The Royal Marsden Hospital, London, UK., Jean-Yves Blay; Centre Léon Bérard, Lyon, France.; Unicancer, Paris, France., Renouf DJ; BC Cancer - Vancouver Centre, Vancouver, Canada., Doi T; National Cancer Center Hospital East, Kashiwa, Japan., Le Cesne A; Institut Gustave Roussy, Villejuif Cedex, France., Leahy M; The Christie Hospital, Manchester, UK., Hertle S; Novartis Pharma AG, Basel, Switzerland., Aimone P; Novartis Pharma AG, Basel, Switzerland., Brandt U; Novartis Pharma AG, Basel, Switzerland., Schӧffski P; University Hospitals Leuven, Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
Publikováno v:
British journal of cancer [Br J Cancer] 2020 Apr; Vol. 122 (8), pp. 1158-1165. Date of Electronic Publication: 2020 Mar 09.
Autor:
Serrano C; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA. cserrano@vhio.net.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. cserrano@vhio.net.; Sarcoma Translational Research Laboratory, Vall d'Hebron Institute of Oncology; Department of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. cserrano@vhio.net., Mariño-Enríquez A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA., Tao DL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA., Ketzer J; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Eilers G; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA., Zhu M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA., Yu C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, USA.; Daiichi Sankyo Inc., Basking Ridge, NJ, USA., Mannan AM; Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, USA., Rubin BP; Department of Molecular Genetics, Lerner Research Institute and Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, USA., Demetri GD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ludwig Center for Cancer Research at Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Raut CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Surgical Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, 75 Francis Street, Boston, MA, USA., Presnell A; Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, Oregon, USA., McKinley A; Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, Oregon, USA., Heinrich MC; Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, Oregon, USA., Czaplinski JT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sicinska E; Department of Oncologic Pathology, Dana Farber Cancer Institute, Boston, MA, USA., Bauer S; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., George S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Fletcher JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA. jfletcher@partners.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. jfletcher@partners.org.
Publikováno v:
British journal of cancer [Br J Cancer] 2019 Mar; Vol. 120 (6), pp. 612-620. Date of Electronic Publication: 2019 Feb 22.